MENU
+Compare
BMRA
Stock ticker: NASDAQ
AS OF
Apr 24, 04:57 PM (EDT)
Price
$3.75
Change
+$0.09 (+2.46%)
Capitalization
14M

BMRA Biomerica Forecast, Technical & Fundamental Analysis

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions... Show more

BMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BMRA with price predictions
Apr 23, 2025

BMRA's Stochastic Oscillator sits in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BMRA's RSI Oscillator exited the oversold zone, of 39 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BMRA advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

BMRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BMRA as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BMRA turned negative on April 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

BMRA moved below its 50-day moving average on March 26, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BMRA crossed bearishly below the 50-day moving average on March 28, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BMRA entered a downward trend on April 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.528) is normal, around the industry mean (23.728). P/E Ratio (0.000) is within average values for comparable stocks, (81.831). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (2.469) is also within normal values, averaging (41.794).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BMRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
BMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BMRA is expected to report earnings to fall 133.33% to 3 cents per share on August 25

Biomerica BMRA Stock Earnings Reports
Q2'23
Est.
$0.04
Q1'23
Missed
by $0.14
Q4'22
Missed
by $0.12
Q3'22
Missed
by $0.14
Q2'22
Missed
by $0.02
The last earnings report on April 14 showed earnings per share of -11 cents, missing the estimate of 1 cents. With 22.11K shares outstanding, the current market capitalization sits at 14.00M.
A.I. Advisor
published General Information

General Information

a maker of medical diagnostic products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
17571 Von Karman Avenue
Phone
+1 949 645-2111
Employees
62
Web
https://www.biomerica.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYGR3.480.11
+3.26%
Voyager Therapeutics
XMTR23.810.47
+1.99%
Xometry
ZM72.831.10
+1.53%
Zoom Communications Inc
SDOT1.670.02
+1.52%
Sadot Group Inc
WD75.310.90
+1.21%
Walker & Dunlop

BMRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRA has been loosely correlated with ZIMV. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRA jumps, then ZIMV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRA
1D Price
Change %
BMRA100%
+6.27%
ZIMV - BMRA
39%
Loosely correlated
+1.74%
LFWD - BMRA
31%
Poorly correlated
+2.45%
NVCR - BMRA
28%
Poorly correlated
+7.63%
CTKB - BMRA
25%
Poorly correlated
-0.40%
SINT - BMRA
24%
Poorly correlated
+28.57%
More